Notification Detail | TRIS - European Commission

Ordinance amending the Narcotic Drugs Control Ordinance (1992:1554)

Notification Number:

2024/0319/SE (Sweden)

Date received:

13/06/2024

End of Standstill:

Not applicable (closed)

Invocation of the Emergency Procedure:

Yes

Draft Text:

SV BG HR CS DA NL EN ET FI FR GA DE EL HU IT LV LT MT PL PT RO SK SL ES

Impact assessment:

SV EN FR DE

Final Text:

SV BG CS DA DE EL EN ES ET FI FR GA HR HU IT LT LV MT NL PL PT RO SK SL

Click here for a printable version of this page

Message

Message 001

Communication from the Commission - TRIS/(2024) 1552

Directive (EU) 2015/1535

Notification: 2024/0319/SE

Notification of a draft text from a Member State

Notification – Notification – Notifzierung – Нотификация – Oznámení – Notifikation – Γνωστοποίηση – Notificación – Teavitamine – Ilmoitus – Obavijest – Bejelentés – Notifica – Pranešimas – Paziņojums – Notifika – Kennisgeving – Zawiadomienie – Notificação – Notificare – Oznámenie – Obvestilo – Anmälan – Fógra a thabhairt

Does not open the delays - N'ouvre pas de délai - Kein Fristbeginn - Не се предвижда период на прекъсване - Nezahajuje prodlení - Fristerne indledes ikke - Καμμία έναρξη προθεσμίας - No abre el plazo - Viivituste perioodi ei avata - Määräaika ei ala tästä - Ne otvara razdoblje kašnjenja - Nem nyitja meg a késéseket - Non fa decorrere la mora - Atidėjimai nepradedami - Atlikšanas laikposms nesākas - Ma jiftaħx il-perijodi ta’ dewmien - Geen termijnbegin - Nie otwiera opóźnień - Não inicia o prazo - Nu deschide perioadele de stagnare - Nezačína oneskorenia - Ne uvaja zamud - Inleder ingen frist - Ní osclaíonn sé na moilleanna

MSG: 20241552.EN

1. MSG 001 IND 2024 0319 SE EN 13-06-2024 SE NOTIF

2. Sweden

3A. Kommerskollegium

3B. Socialdepartementet, Regeringskansliet

4. 2024/0319/SE - C10P - Pharmaceuticals

5. Ordinance amending the Narcotic Drugs Control Ordinance (1992:1554)

6. Narcotic drugs

7.

8. On the basis of the attached classification document, the Swedish Medical Products Agency proposes that the substances rilmazafone and rilmazolam shall be classified as narcotic drugs under the Narcotic Drugs Control Act (1992:860), and the Narcotic Drugs Penal Act (1968:64) and shall be included in the Narcotic Drugs Control Ordinance (1992:1554). Such classification means, inter alia, that these substances may not be imported or possessed without special permission from the Swedish Medical Products Agency.

9. It is proposed that rilmazafone and rilmazolam should belong to the group hypnotics and tranquillisers. After ingestion, the substance rilmazafone is converted into the substance rilmazolam, which has psychoactive properties. In Sweden, four deaths have been linked to the ingestion of rilmazafone, and there is abuse of the substance in the country. In all cases, rilmazolam was deemed to have caused or contributed to the deaths. Rilmazafone has been found to be available for sale in online outlets. For all the substances, there is scientific documentation supporting the narcotics criteria.

10. Reference(s) to basic text(s): No basic texts available

11. Yes

12. Risks to human life and health, and to public safety, mean that the Regulation amendments regarding the substances to be classified as narcotic drugs should be drawn up within a very short time frame.

13. No

14. No

15. Yes

16.
TBT aspects: No

SPS aspects: No

**********
European Commission
Contact point Directive (EU) 2015/1535
email: grow-dir2015-1535-central@ec.europa.eu

Disclosed messages

message-id	Year	Number	Country	Type	Title	Date received
108465	2024	1553	COMEuropean Commission	037	Competitiveness analysis	13-06-2024
108561	2024	1633	COMEuropean Commission	013	Acceptance of Emergency Request + Closure of Information Procedure	24-06-2024
108910	2024	1965	COMEuropean Commission	049	Acknowledgement of receipt of the adopted text	19-07-2024

Languages

Stakeholders Contributions

The TRIS website makes it easy for you or your organization to share your views on any given notification.

Due the notification’s status or the end of standstill, we are currently not accepting any further contributions for this notification via the website.

No contributions were found for this notification